Balaxi Pharmaceuticals Ltd Share Price
(BALAXI)
₹63.92
as on 04:01PM, 28 Mar 2025
Balaxi Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹62.31Day's Price Range₹65.952 Week's Low
52 Week's High
₹50.4252-Week Price Range₹151.45
| Returns % | |
| 1 Month Return | + 21.5 % |
| 3 Month Return | -9.75 % |
| 1 Year Return | -34.71 % |
| Market Stats | |
| Previous Close | ₹64.76 |
| Open | ₹65.00 |
| Volume | 1.58L |
| Upper Circuit | ₹71.23 |
| Lower Circuit | ₹58.28 |
| Market Cap | ₹357.52Cr |
Balaxi Pharmaceuticals Ltd Fundamentals
P/E Ratio
12.79
PEG Ratio
2.1
Market Cap
₹357.52 Cr
P/B Ratio
4.59
EPS
-0.438
Dividend Yield
0Sector
Pharmaceuticals
ROE
3.42
Key events for Balaxi Pharmaceuticals Ltd
Balaxi Pharmaceuticals Stock Surges Amid Heavy Buying - 07 Mar, 2025
Balaxi Pharmaceuticals shares rose over 35% in four sessions, gaining 20% in one day. FIIs hold 16% stake, while the stock has seen significant demand despite past declines.Balaxi Pharmaceuticals Stock Surges After Bulk Deals - 05 Mar, 2025
Balaxi Pharmaceuticals shares jumped over 22% in two days following significant bulk deals. The company reported a 20.6% year-on-year increase in operational revenue.Balaxi Pharma Shares Surge After FII Stake Acquisition - 04 Mar, 2025
Shares of Balaxi Pharmaceuticals rose nearly 14% following a bulk deal where foreign investors acquired over 16% stake. Despite revenue growth, net profit and EBITDA declined significantly year-on-year.Significant Share Transactions in Balaxi Pharmaceuticals - 03 Mar, 2025
On March 3, 2025, Ebisu Global Opportunities Fund and Unico Global Opportunities Fund acquired significant stakes in Balaxi Pharmaceuticals at Rs 53 per share, while MGC Fund and Elala India Opportunities Fund sold equivalent shares. The promoter group holds 65.99% of the company.Balaxi Pharma Reports Mixed Financial Results - 20 Feb, 2025
Balaxi Pharma's December 2024 net sales rose 20.57% to Rs 73.29 crore, but net profit fell 60.55% to Rs 5.36 crore. EPS decreased significantly, reflecting ongoing challenges.
Insights on Balaxi Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 4 quarters, 59.14 Cr → 77.23 Cr (in ₹), with an average increase of 8.5% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, BALAXI stock has moved up by 21.5%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 4.59 Cr → 5.36 Cr (in ₹), with an average increase of 14.4% per quarter
NO EFFECTRetail Holding Unchanged
Retail Investor holdings remained unchanged at 17.50% of holdings in Dec 2024 quarter
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 65.99% of holdings in Dec 2024 quarter
- NO EFFECT
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 16.48% of holdings in Dec 2024 quarter
Balaxi Pharmaceuticals Ltd Financials
Balaxi Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 65.99% | 0.00 | |
| Foreign Institutions | 16.48% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 17.5% | 0.00 | |
| Others | 0.02% | 0.00 |
Balaxi Pharmaceuticals Ltd Key Indicators
Balaxi Pharmaceuticals Ltd Valuation
Balaxi Pharmaceuticals Ltd in the last 5 years
Lowest (-263.96x)
May 28, 2024
Today (12.79x)
March 27, 2025
Industry (53.19x)
March 27, 2025
Highest (66.45x)
September 21, 2020
Balaxi Pharmaceuticals Ltd Earnings and Dividends
Balaxi Pharmaceuticals Ltd Earnings Results
Balaxi Pharmaceuticals Ltd’s net profit fell -60.56% since last year same period to ₹5.36Cr in the Q3 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 16.78% jump in its net profits since last 3-months.
Read More about Earnings ResultsBalaxi Pharmaceuticals Ltd Dividends May,2022
In the quarter ending March 2022, Balaxi Pharmaceuticals Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.78%.
Read More about Dividends
Balaxi Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Balaxi Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Balaxi Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹357.52 Cr | 71.28% | 0.56 | -₹3 Cr | ₹241 Cr | |
| NA | ₹236.89 Cr | 278.53% | 0.58 | -₹12 Cr | ₹15 Cr | |
| NA | ₹3,516.02 Cr | 68.2% | 0.58 | -₹154 Cr | ₹2,615 Cr | |
| NA | ₹3,325.20 Cr | 126.56% | 0.70 | ₹86 Cr | ₹806 Cr | |
| NA | ₹41.74 Cr | 11.19% | 0.51 | ₹1 Cr | ₹62 Cr |
About Balaxi Pharmaceuticals Ltd
In March 2017, Balaxi Overseas Pvt Ltd acquired 16,700,036 (54.94%) equity shares of the company along with its control and management. Its representatives became the new directors and the company was renamed to Balaxi Ventures. A preferential issue of 6,960,000 equity shares was approved in July 2019 and allotted in August, increasing the company’s paid-up share capital to Rs 100,000,000. Following this, Balaxi Ventures started international wholesale trading in pharmaceutical products, builders hardware, and recently launched YAP food products.
Revenue: ₹73.29Cr as on December 2024 (Q4 24)
Net Profit: ₹5.36Cr as on December 2024 (Q4 24)
Listing date: 30 Nov, 2015
Chairperson Name: Ashish Maheshwari
| Organisation | Balaxi Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Balaxi Pharmaceuticals Ltd
What is Balaxi Pharmaceuticals Ltd price today?
Balaxi Pharmaceuticals Ltd share price today stands at ₹63.92, Open: ₹65, Previous Close: ₹64.76, High: ₹65.9, Low: ₹62.31, 52 Week High: ₹151.45, 52 Week Low: ₹50.42.
How to Buy Balaxi Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Balaxi Pharmaceuticals Ltd shares
What are today's traded volumes of Balaxi Pharmaceuticals Ltd?
Today's traded volume of Balaxi Pharmaceuticals Ltd(BALAXI) is 1.58L.
What is today's market capitalisation of Balaxi Pharmaceuticals Ltd?
Today's market capitalisation of Balaxi Pharmaceuticals Ltd(BALAXI) is ₹357.52Cr.
What is the 52 Week High and Low Range of Balaxi Pharmaceuticals Ltd?
How much percentage Balaxi Pharmaceuticals Ltd is down from its 52 Week High?
Balaxi Pharmaceuticals Ltd (BALAXI) share price is ₹63.92. It is down -57.79% from its 52 Week High price of ₹151.45
How much percentage Balaxi Pharmaceuticals Ltd is up from its 52 Week low?
Balaxi Pharmaceuticals Ltd (BALAXI) share price is ₹63.92. It is up 26.78% from its 52 Week Low price of ₹50.42